These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14530769)

  • 1. Xenon in intensive care.
    Marx T
    Crit Care Med; 2003 Oct; 31(10):2556-7. PubMed ID: 14530769
    [No Abstract]   [Full Text] [Related]  

  • 2. How does xenon produce anaesthesia?
    Franks NP; Dickinson R; de Sousa SL; Hall AC; Lieb WR
    Nature; 1998 Nov; 396(6709):324. PubMed ID: 9845069
    [No Abstract]   [Full Text] [Related]  

  • 3. Xenon as an anesthetic agent.
    Jordan BD; Wright EL
    AANA J; 2010 Oct; 78(5):387-92. PubMed ID: 21067086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenon: no stranger to anaesthesia.
    Sanders RD; Franks NP; Maze M
    Br J Anaesth; 2003 Nov; 91(5):709-17. PubMed ID: 14570795
    [No Abstract]   [Full Text] [Related]  

  • 5. Xenon in anesthesia.
    Aziz TS
    Int Anesthesiol Clin; 2001; 39(2):1-14. PubMed ID: 11507374
    [No Abstract]   [Full Text] [Related]  

  • 6. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor by the anesthetics xenon and isoflurane: evidence from molecular modeling and electrophysiology.
    Dickinson R; Peterson BK; Banks P; Simillis C; Martin JC; Valenzuela CA; Maze M; Franks NP
    Anesthesiology; 2007 Nov; 107(5):756-67. PubMed ID: 18073551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xenon: recent developments.
    Dingley J; Ivanova-Stoilova TM; Grundler S; Wall T
    Anaesthesia; 1999 Apr; 54(4):335-46. PubMed ID: 10455831
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroprotection against traumatic brain injury by xenon, but not argon, is mediated by inhibition at the N-methyl-D-aspartate receptor glycine site.
    Harris K; Armstrong SP; Campos-Pires R; Kiru L; Franks NP; Dickinson R
    Anesthesiology; 2013 Nov; 119(5):1137-48. PubMed ID: 23867231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of xenon as a sedative for patients receiving critical care.
    Bedi A; Murray JM; Dingley J; Stevenson MA; Fee JP
    Crit Care Med; 2003 Oct; 31(10):2470-7. PubMed ID: 14530753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective interaction produced by xenon and dexmedetomidine on in vitro and in vivo neuronal injury models.
    Rajakumaraswamy N; Ma D; Hossain M; Sanders RD; Franks NP; Maze M
    Neurosci Lett; 2006 Dec; 409(2):128-33. PubMed ID: 17052852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that Xenon does not produce open channel blockade of the NMDA receptor.
    Weigt HU; Adolph O; Georgieff M; Georgieff EM; Föhr KJ
    J Neurophysiol; 2008 Apr; 99(4):1983-7. PubMed ID: 18234987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xenon as an anaesthetic gas.
    Baskar N; Hunter JD
    Br J Hosp Med (Lond); 2006 Dec; 67(12):658-61. PubMed ID: 17328451
    [No Abstract]   [Full Text] [Related]  

  • 13. [Low flow anesthesia with xenon].
    Baum J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Jan; 32(1):51-5. PubMed ID: 9138549
    [No Abstract]   [Full Text] [Related]  

  • 14. Will xenon be a stranger or a friend?: the cost, benefit, and future of xenon anesthesia.
    Goto T; Nakata Y; Morita S
    Anesthesiology; 2003 Jan; 98(1):1-2. PubMed ID: 12502969
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroprotection by nitrous oxide and xenon and its relation to minimum alveolar concentration.
    Abraini JH; David HN; Nicole O; MacKenzie ET; Buisson A; Lemaire M
    Anesthesiology; 2004 Jul; 101(1):260-1; author reply 261. PubMed ID: 15220810
    [No Abstract]   [Full Text] [Related]  

  • 16. Contrasting roles of the N-methyl-D-aspartate receptor in the production of immobilization by conventional and aromatic anesthetics.
    Eger EI; Liao M; Laster MJ; Won A; Popovich J; Raines DE; Solt K; Dutton RC; Cobos FV; Sonner JM
    Anesth Analg; 2006 May; 102(5):1397-406. PubMed ID: 16632817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenon reduces N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor-mediated synaptic transmission in the amygdala.
    Haseneder R; Kratzer S; Kochs E; Eckle VS; Zieglgänsberger W; Rammes G
    Anesthesiology; 2008 Dec; 109(6):998-1006. PubMed ID: 19034096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Xenon and other volatile anesthetic agents- mode of action].
    Hecker K; Rossaint R
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Oct; 36(10):644-6. PubMed ID: 11592027
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial III: xenon--cardiovascularly inert?
    Preckel B; Schlack W
    Br J Anaesth; 2004 Jun; 92(6):786-9. PubMed ID: 15145831
    [No Abstract]   [Full Text] [Related]  

  • 20. Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane.
    Gruss M; Bushell TJ; Bright DP; Lieb WR; Mathie A; Franks NP
    Mol Pharmacol; 2004 Feb; 65(2):443-52. PubMed ID: 14742687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.